The Pharmaceutical Research and Manufacturers Association Gulf

What The Pharmaceutical Research and Manufacturers Association Gulf does

The Pharmaceutical Research and Manufacturers Association Gulf (PHRMAG) is a non-profit industry association established in 2005 and headquartered in Dubai, United Arab Emirates. It represents 30 leading innovative biopharmaceutical research companies operating across the Gulf Cooperation Council (GCC) — covering the UAE, Saudi Arabia, Qatar, Oman, Bahrain, and Kuwait. Its function is to serve as the collective voice and bridge between multinational pharmaceutical innovators and regional government health authorities, advocating for policies that support medical research, intellectual property protection, regulatory maturity, and patient access to advanced therapies. PHRMAG does not sell commercial products; rather, it operates as a membership-based association funded through undisclosed dues and partnership/sponsorship revenue.

PHRMAG's core "offerings" are structured industry initiatives rather than technology products. These include: (1) Industry advocacy and policy leadership, engaging health authorities on regulatory frameworks and IP protection; (2) the Innovation Enablers platform, convening government, healthcare, and industry leaders around incentives and IP rights for healthcare innovation; (3) the MEA Code of Promotional Practices — a binding ethical code first enacted in 2005 (current version effective January 1, 2022) covering Real World Evidence, post-marketing studies, events, medical education, and patient organization interactions for all member companies; (4) academic partnership programs, including lead sponsorship of NYU Abu Dhabi's GradSlam 2025 to support STEM talent and life sciences innovation; and (5) a structured committee network spanning Executive Committee, Compliance & Legal, Value & Access, Intellectual Property & Policy, plus country-specific working groups across all GCC markets.

Its business model centers on membership dues from 30 biopharmaceutical companies (including senior-executive participation from Pfizer, Johnson & Johnson, and Eli Lilly on the Executive Committee), supplemented by event sponsorship and project-based partnerships. The association employs 51-100 staff and generates revenue through undisclosed channels. PHRMAG's customer base consists of its biopharmaceutical member companies and government health authority counterparties across the GCC; its "go-to-market" is relationship-driven engagement rather than transactional sales, executed through high-level workshops (e.g., UAE Ministry of Economy & Tourism IP workshop, February 2026), international conference participation (79th World Health Assembly, BIO International Convention, MIT Solve Future Health Challenge), and academic collaborations.

Name

The Pharmaceutical Research and Manufacturers Association Gulf

Legal name

The Pharmaceutical Research and Manufacturers Association Gulf (PHRMAG)

Website

https://phrmag.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

51–100 employees

Short description

PHRMAG is a Dubai-based non-profit industry association, founded in 2005, that represents 30 leading innovative biopharmaceutical research companies across the six GCC countries, advocating for healthcare policy, regulatory frameworks, IP protection, and ethical standards through member-driven committees and government engagement.

Ownership category

akta.pro rank

Headquarters

HQ city

Dubai

HQ country

United Arab Emirates

HQ region

Middle East

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Marketing channels3 records

Core offering

PHRMAG is the Gulf region's industry association for 30 innovative biopharmaceutical research companies. It provides policy advocacy, regulatory engagement, ethical standards enforcement via the MEA Code of Promotional Practices, academic research partnerships, and a structured committee network to address industry challenges across the Gulf Cooperation Council (GCC).

Product overview

PHRMAG is a membership-based industry association representing 30 innovative biopharmaceutical research companies operating in the Gulf region. Rather than offering a commercial product or platform, PHRMAG provides a suite of collaborative initiatives including policy advocacy and regulatory engagement through its Innovation Enablers platform, ethical standards enforcement via the MEA Code of Promotional Practices, academic research partnerships, and a structured committee network addressing compliance, access, IP policy, and regional coordination across GCC markets.

Differentiator

Problem solved

Functional benefit

Products and services

• Innovation Enablers Initiative A platform initiative bringing together government, healthcare, and industry leaders to emphasize incentives, regulatory policies, and IP rights protection for driving healthcare innovation in the UAE and Gulf region.
• MEA Code of Promotional Practices A binding ethical code governing promotional practices, post-marketing studies, medical education support, and patient organization interactions for member companies. The current version came into effect on January 1, 2022, covering Real World Evidence, Post Marketing Assessments, Events & Hospitality, Medical Education, and Pharmaceutical Industry and Patient Organisation interactions.
• Academic Partnership Programs Collaborations with academic institutions such as NYU Abu Dhabi to support research excellence, talent development, and innovation in life sciences across the UAE and Gulf region.
• Committee and Working Group Network Structured committees including Executive Committee, Compliance and Legal, Value and Access, IP and Policy, and regional working groups covering GCC countries to address industry challenges and shape policy.

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

15 partnerships are on record, tiered core and supporting.

• Future Health - A Global Initiative by Abu DhabicoreStrategic or Co-development Partner · 1 May 2026PHRMAG attended the Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing, delivered by Future Health in collaboration with MIT Solve. The engagement reflected Abu Dhabi's forward-looking vision to support the global shift from reactive healthcare to more predictive, preventive, and resilient models of care.
• CASCI - Arab Swiss Chamber of Commerce and IndustrysupportingStrategic or Co-development Partner · 1 May 2026PHRMAG took part in a high-level health dialogue hosted by CASCI under the patronage of H.E. Dr. Hilal bin Ali bin Hilal Al Sabti, Minister of Health of Oman, and the Permanent Mission of Oman to the United Nations. The dialogue brought together senior leaders to discuss resilient health systems, pharmaceutical economics, medicine security, and cross sector partnerships.
• UAE Ministry of Economy & TourismcoreStrategic or Co-development Partner · 1 February 2026PHRMAG participated in a high-level strategic workshop with the UAE Ministry of Economy & Tourism alongside H.E. Abdullah Ahmed Al Saleh, Undersecretary of the Ministry. The workshop focused on strengthening intellectual property ecosystems that support innovation and sustainable growth across the life sciences and pharmaceutical sectors.
• NYU Abu DhabicoreStrategic or Co-development Partner · 1 November 2025PHRMAG joined as Lead Sponsor of NYUAD's GradSlam research communication competition for graduate students. The collaboration aims to support STEM talent development and life sciences innovation in the UAE and Gulf region, aligning with the UAE's goal of establishing itself as a global life sciences hub including the recently launched HELM (Health, Endurance, Longevity, and Medicine) cluster. The partnership was announced during PHRMAG's 20th anniversary year.
• Emirates Health Economics Society (EHES)supportingStrategic or Co-development Partner · 1 January 2025PHRMAG conducted a workshop with EHES focusing on health economics aspects of pharmaceutical sector.
• ISPOR UAE ChaptersupportingStrategic or Co-development Partner · 1 January 2025PHRMAG participated in ISPOR UAE Chapter Conference 2026 and 2025 events, engaging in health economics and outcomes research discussions.
• U.S. Chamber of CommercesupportingStrategic or Co-development Partner · 1 January 2025PHRMAG participated in U.S. Chamber of Commerce roundtable at BIO 2025, fostering cross-border healthcare industry dialogue.
• ACMA (Accreditation Council for Medical Affairs)supportingStrategic or Co-development Partner · 1 December 2023PHRMAG partnered with ACMA to launch the region's first PACS (Pre-Approved Clinical Saq) program to ease insurance approval processes for patients.
• G42 HealthcaresupportingStrategic or Co-development Partner · 1 June 2023PHRMAG visited G42 Healthcare Omics Center of Excellence to explore collaboration opportunities in advanced healthcare technologies.
• Department of Health Abu DhabicoreStrategic or Co-development Partner · 1 January 2023PHRMAG joined DOH Abu Dhabi at the Bio International Convention 2023 to represent the Gulf biopharma industry and discuss collaboration opportunities.
• UAE Ministry of Health and Prevention (MOHAP)coreStrategic or Co-development Partner · 1 January 2023PHRMAG joined UAE MOHAP at Bio International Convention 2023 to engage with regulatory authorities on pharmaceutical policy matters.
• Qatar Cancer SocietysupportingStrategic or Co-development Partner · 1 January 2023PHRMAG collaborated with Qatar Cancer Society to host a workshop on cancer care and treatment access.
• Bahrain National Health Regulatory AuthoritycoreStrategic or Co-development Partner · 1 January 2023PHRMAG served as Gold Sponsor at the 3rd Health Regulatory Conference in Bahrain, engaging with regulatory stakeholders across the region.
• NHRA Bahrain and Saba IPsupportingStrategic or Co-development Partner · 1 December 2022PHRMAG partnered with NHRA Bahrain and Saba IP on IP Fundamentals to strengthen intellectual property awareness in the region.
• Kuwait Ministry of HealthcoreStrategic or Co-development Partner · 1 January 2022PHRMAG collaborated with Kuwait Ministry of Health to host a workshop on improving access to medicine.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Pharmaceutical Research and Manufacturers of America (PhRMA): The US national trade association for innovative biopharmaceutical research companies. PhRMA is the most direct structural analogue to PHRMAG: member-driven advocacy, code of ethics, regulatory engagement, and policy leadership on behalf of innovative pharma R&D.
• European Federation of Pharmaceutical Industries and Associations (EFPIA): Europe's regional pharma industry association, representing innovative research-based companies. Highly comparable to PHRMAG in mandate (regulatory advocacy, IP, market access) and structure (member companies, codes of practice, working groups).
• Biotechnology Innovation Organization (BIO): Global biotechnology trade association representing innovative biopharma and biotech companies. Directly comparable as PHRMAG participates in BIO International Convention and both organizations serve as convening bodies for innovative biopharma companies engaging with policymakers.
• International Federation of Pharmaceutical Manufacturers & Associations (IFPMA): Global umbrella federation of pharma industry associations. Comparable as the apex body that PHRMAG-style regional associations either affiliate with or mirror structurally; both focus on policy advocacy, ethics codes, and global health partnerships.

Regional players

• Japan Pharmaceutical Manufacturers Association (JPMA): Japan's national pharma industry association. Operates a similar association model with self-regulatory codes and policy advocacy, but serves a different geography (Japan vs. Gulf) and is therefore a regional rather than direct competitor.
• Association of the British Pharmaceutical Industry (ABPI): UK pharma industry association with mandatory Code of Practice for member companies. Comparable structurally (member-driven, ethics code, policy engagement) but operates in the UK market rather than the Gulf.
• Medicines Australia: Australia's national pharma industry association. Comparable association model with codes of conduct and policy advocacy responsibilities, but serving the Australian market rather than the Gulf region.
• Indian Pharmaceutical Alliance (IPA): India's research-based pharmaceutical industry association. Comparable in function (industry advocacy, ethics, regulatory engagement) but focused on the Indian market rather than the Gulf.
• LEEM (Les Entreprises du Médicament): France's national pharma industry association. Similar association model with policy advocacy, regulatory engagement, and member codes of practice, but serves the French market.
• Innovative Medicines Canada (IMC): Canada's national association for innovative pharmaceutical companies. Comparable in structure and mission (advocacy for R&D pharma, code of ethics, government engagement) but operates in the Canadian market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Customer concentration

• LinkedInlinkedin.com/company/phrmag
• Xx.com/phrmagforum

Revenue estimate

Valuation estimate

Number of profiles

Profiles18 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Pharmaceutical Research and Manufacturers Association Gulf